Nội dung chính của bài viết
Tobacco smoking remains a leading cause of preventable diseases and premature death in many countries. Many smokers want to quit smoking but are not offered the highly effective treatments available to manage tobacco dependency. There has been a current trend for researchers to find new natural ingredients that were safe and still effective in treating tobacco dependence. BTL tea was a herbal-derived product prepared from Herba Menthae, Pogos cablin (Blanco) Benth., Zingiber Officinale Rosc., Flos Chrysanthemi, Radix Glycyrrhizae, Pericarpium Citri deliciosa, and Flos Lonicera. At this time, the safety of this product has not been reported. Thus, this study aimed to evaluate BTL tea’s acute and subchronic toxicity through oral administration in experimental animals. The acute toxicity was determined by Litchfield-Wilcoxon method in mice at the doses of 45.0 g/kg b.w/day to 112.5 g/kg b.w/day. The subchronic toxicity was evaluated following WHO and OECD’s Guidelines in rats with oral doses of 1.08 g/kg b.w/day (equal to recommended human dose) and 3.24 g/kg b.w/day (three times as high as recommended human dose) for four consecutive weeks. As a result, in the acute toxicity test, the mice showed no abnormal sign or death. The subchronic toxicity test, hematological indexes, hepato-renal functions, and microscopic images of liver and kidney were unchanged. However, compared with the control group, there were significant differences in various indexes, including total WBC, lymphocytes, neutrophils, and AST level, but the levels were still safe. In conclusion, BTL tea does not appear to produce acute and subchronic toxicities in mice and rats.
Chi tiết bài viết
BTL tea, acute toxicity, subchronic toxicity, experimental animals
Tài liệu tham khảo
2. Buchhalter AR, Fant RV, Henningfield JE. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Drugs. 2008;68(8):1067-88.
3. Guite NT. International Protocol and Indigenous Knowledge on Medicine and Health Care: An overview. The Asian Man. 2010;1(4):01-12.
4. World Health Organization, Global report on traditional and complementary medicine. 2019.
5. Venkatasubbu GD, Ramasamy S, Gaddam PR, et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine. 2015;10:137-148.
6. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices. 2012;120-158.
7. OECD, Guidelines for the testing of chemicals repeated dose oral toxicity study in rodents, Environmental Health and Safety Monograph Series on Testing and Assesment No 407; 2008.
8. World Health Organization. Guidelines for Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues. Geneva; 2007.
9. Litchfield J T, Wilcoxon F A. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949;96:99-113.
10. World Health Organization. Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization; 2000.
11. National Research Council. Toxicity testing for assessing environmental agents. Interim Report. Washington, DC, USA: National Academies Press; 2006.
12. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology. 2000;32(1):56-67.
13. Xianglu Ronga, Gang Pengc, Takuya Suzuki, et al. A 35-day gavage safety assessment of ginger in rats. Regul Toxicol Pharmacol. 2009;54(2):118-123.
14. Shen H, Guo Q, Fang H. Toxicological evaluation of carotenoid-type extracts from Flos Chrysanthemi Indici. Journal of Medicinal Plants Research. 2011;5(23):5507-5512.